US 9757420
Gene editing for HIV gene therapy
granted A61KA61K35/28A61K48/00
Quick answer
US patent 9757420 (Gene editing for HIV gene therapy) held by Sangamo Therapeutics, Inc. expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K35/28, A61K48/00